Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.01 (0.45%)
Bid:
2.01
Ask:
2.19
Spread: 0.18 (8.955%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Director/PDMR Shareholding

26 Mar 2025 12:46

RNS Number : 3456C
Quadrise PLC
26 March 2025
 

26 March 2025

 

Quadrise Plc ("Quadrise" or the "Company")

 

Director/PDMR Shareholding

 

Quadrise Plc (AIM: QED), the transition technology provider for a cleaner planet, announces that Philip Hill, Chief Operating Officer of the Company, has on 26 March 2025 sold 116,666 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at a price of 3.921 pence per Ordinary Share (the "Sale"), and also simultaneously purchased 116,666 ordinary shares at a price of 3.970 pence per Ordinary Share (the "Purchase" and, together with the Sale, the "Dealings").

 

The Dealings have been undertaken in order to effect a transfer of the Ordinary Shares subscribed for by Mr Hill in the Company's £6.53 million fundraising into an ISA.

 

Following the Dealings, Mr Hill's beneficial holding is 338,363 Ordinary Shares, representing approximately 0.02 per cent. of the Company's issued share capital.

 

The notification below, made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

 

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

Joint Brokers

Shore Capital Stockbrokers Limited

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

+44 (0)20 7408 4090

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Cutbill Jacoby

Andy Cutbill

Frankie Dundon

 

+44 (0)7841 576000

+44 (0)7312 274086

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Philip Hill

 

2

Reason for notification

a)

Position/Status

PDMR (Chief Operating Officer)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Quadrise plc

 

b)

LEI

213800HN2ETG5476U328

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 1 pence each

 

ISIN: GB00B11DDB67

 

b)

Nature of transaction

Sale of Ordinary Shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

3.921 pence

116,666

 

 

d)

Aggregated information

 n/a

 

 

e)

Date of transaction

26 March 2025

 

 

f)

Place of transaction

AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Philip Hill

 

2

Reason for notification

a)

Position/Status

Chief Operating Officer 

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Quadrise plc

 

b)

LEI

213800HN2ETG5476U328

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 1 pence each

 

ISIN: GB00B11DDB67

 

b)

Nature of transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

3.970 pence

116,666

 

 

d)

Aggregated information

 n/a

 

 

e)

Date of transaction

26 March 2025

 

 

f)

Place of transaction

AIM

 

 

 

About Quadrise Plc

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X (formerly Twitter): @QuadrisePlc

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUQCWUPAGPQ
Date   Source Headline
15th Apr 20267:00 amRNSDirectorate change
23rd Mar 20267:00 amRNSInterim Results & Notice of Investor Presentation
19th Mar 20267:00 amRNSAppointment of Non-Executive Director
3rd Feb 20267:00 amRNS-RPublication of 2025 Sustainability Report
12th Jan 20267:00 amRNSExtension of Exclusive Agreement with Nouryon
9th Jan 20267:00 amRNSDirector/PDMR Shareholding and Directorate Change
4th Dec 202512:17 pmRNSDirector/PDMR Shareholding
28th Nov 20252:55 pmRNSResult of AGM
28th Nov 20257:00 amRNSAGM Statement
7th Nov 20253:01 pmRNSDirector/PDMR Shareholding
6th Nov 20251:46 pmRNSDirector/PDMR Shareholding
28th Oct 20255:23 pmRNSPosting of Annual Report and Notice of AGM
27th Oct 20257:00 amRNSIssue of Options and Director Dealing
13th Oct 20257:00 amRNSIssue of Share Options and Director/PDMR Dealing
29th Sep 20257:00 amRNSFinal Results and Notice of AGM
26th Sep 20257:00 amRNSValkor update
17th Sep 20257:00 amRNSSuccessful Sparkle Power Programme Testing
15th Sep 20257:00 amRNSCEO Appointment
18th Aug 20257:00 amRNSBusiness Update
25th Jul 20257:00 amRNSDirector / PDMR Shareholding
14th Jul 20258:00 amRNSDirector/PDMR Shareholding
4th Jul 202511:50 amRNSExercise of Options and Total Voting Rights
17th Jun 20257:00 amRNSJoint Development Agreement with Alder Energy LLC
10th Jun 20257:00 amRNSBusiness Update
23rd May 20257:00 amRNSExercise of Warrants
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSManagement Update
3rd Apr 20257:00 amRNSExercise of Share Options
1st Apr 20257:00 amRNSMAC2 Services Agreement
26th Mar 202512:46 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSLicella Joint Development Agreement
24th Mar 20257:00 amRNSInterim Results and Investor Presentation
13th Mar 20257:00 amRNS-RAppointment of Head of Marine
31st Jan 20257:00 amRNSResult of Retail Offer
30th Jan 20252:36 pmRNSIncrease of Retail Offer
28th Jan 20257:00 amRNSAppointment of Director
24th Jan 202510:04 amRNSRetail Offer - Notice of IMC Presentation
24th Jan 20257:05 amRNSRetail Offer
24th Jan 20257:00 amRNSResult of Placing and Subscription
23rd Jan 20254:51 pmRNSProposed Placing, Subscription and Retail Offer
15th Jan 20257:00 amRNSValkor License Revenues
16th Dec 20247:00 amRNSMaterial Transfer Agreement with Sparkle Power SA
5th Dec 20247:00 amRNS-RbioMSAR™ Development Update
26th Nov 20247:00 amRNSProject Agreement with MSC and Cargill
25th Nov 20247:00 amRNSCollaboration Agreement with Auramarine
22nd Nov 20244:57 pmRNSResult of AGM
22nd Nov 20247:00 amRNSAGM Statement
25th Oct 20244:05 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20247:00 amRNSFinal Results and Notice of AGM
2nd Aug 20247:00 amRNSIssue of Share Options and Director/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.